Modifications of the Immune Responsiveness in Patients with Hepatitis C Virus Infection following Treatment with IFN- / Ribavirin

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|11|981-993

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.11, 2002-05, pp. : 981-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Virus Infection: Immune Responsiveness and Interferon-a Treatment

By  

Current Pharmaceutical Design, Vol. 6, Iss. 2, 2000-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-01 ,pp. : 2093-2100

Bentham Science Publishers

Access to resources Recommend Favorite

Recurrent hepatitis C virus (HCV) infection after liver transplantation "can be safely treated" with PEG interferon (IFN)- -2b and ribavirin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Interferon (IFN)-α-2a is effective in patients with hepatitis D virus (HDV) infection, but adjunctive ribavirin does not provide additional benefit

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

IFN- -2b + ribavirin + amantadine for treatment-resistant hepatitis C

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite